GenSight Biologics Reports Estimated Full-Year Consolidated Financial Results for 2025 GenSight Biologics Reports Estimated Full-Year Consolidated Financial Results for 2025 Share Note: See paragraph on Estimated Full-Year 2025 Consolidated Financial Results at the end of this Press Release PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neu ...

My name is Mike and I’m the author of The Dividend Guy Blog & The Dividend Monk along with the owner and portfolio manager here at Dividend Stocks Rock (DSR). I earned my bachelor degree in finance-marketing, own a CFP title along with an MBA in financial services. Besides being a passionate investor, I’m also happily married with three beautiful children. I started my online venture to educate people about investing and to be able to spend more time with my family. I started my career in the financial indu ...

Novartis to buy U.S.-based biotech firm Excellergy for up to $2 billion | Reuters Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv The company's logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz, Switzerland, January 29, 2020. REUTERS/Arnd Wiegmann/File Photo Purchase Licensing Rights, opens new tab March 27 (Reuters) - Swiss pharma company Novartis (NOVN.S), opens new tabsaid on Friday it will acquire California-based biotech company Excellergy ...

Investors took some comfort from U.S. President However, reports that Trump was considering sending more troops added to concern about the war escalating into a ground conflict, with no certainty that the Strait of Hormuz could be reopened to shipping soon. Iran has dismissed a U.S. proposal to end the conflict as "one-sided and unfair".Live Events "It is in everyone's interests for this conflict to be short," said Diana Mousina, deputy chief economist at AMP. "However, that's not how wars often work as ...

Chinese universities with military links bought Super Micro servers with restricted AI chips | Reuters Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv The Super Micro logo is seen in this illustration taken August 3, 2025. REUTERS/Dado Ruvic/Illustration/File Photo Purchase Licensing Rights, opens new tab BEIJING, March 27 (Reuters) - Four Chinese universities, including two linked to the People's Liberation Army, bought Super Micro Computer (SMCI.O), opens new ...

The Nasdaq 100 has crossed a notable threshold, trading below its all-time high for 100 consecutive days. However, with the index hovering less than 10% off its peak, historical data suggests tech investors shouldn’t panic just yet.Rare Setup For Big TechAccording to recent market analysis shared by The Kobeissi Letter, the tech-heavy index has entered a highly unusual consolidation phase.The Nasdaq 100 has now gone 100 days without hitting a new record high, marking its longest such streak since 2023. It m ...

Despite this volatile backdrop, the sector has started 2026 on a strong footing, with demand consistently outpacing supply across the top seven cities, underscoring its structural strength.Also Read: India's ‘Office of the World’ dreams await power measuresAccording to Colliers, supply remained healthy at 11.8 million sq ft, up 19% YoY, led by Bengaluru with a dominant 47% share of completions, followed by Delhi NCR at 17%. Chennai and Mumbai each added about 1.5 million sq ft, contributing roughly 13% eac ...

In this article.NSEIINR=HSBCPeople stand in a queue to refill fuel at a gas station in Guwahati, India, on March 26, 2026.David Talukdar | Anadolu | Getty ImagesForeign investors are on track to pull a record $12 billion from Indian equities this March as the Iran war disrupts oil and gas supplies, squeezing the economy and stoking fears of a growth slowdown.With just two trading days left in the month, foreign portfolio investors have already pulled out 1.12 trillion rupees ($12.1 billion) — likely marking ...

– Acquisition brings together Excellergy's differentiated trifunctional allergic effector cell response inhibitors (ECRIs) and the development expertise of Novartis, with a total potential transaction value of up to $2 billion – – Exl-111 is a potentially first-in-class allergic trifunctional ECRI targeting the IgE axis and is currently in Phase 1 development – PALO ALTO, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Excellergy, a biotechnology company developing a novel class of allergy therapeutics, today an ...

If you want full access to all our reports, data, and investing ideas, join The Aerospace Forum , the #1 aerospace, defense, and airline investment research service on Seeking Alpha, with access to evoX Data Analytics, our in-house developed data analytics platform.In February, I covered Nebius Group ( NBIS ) with a buy rating. Since then, shares of the data center company have advanced 11.1% against a 5.7% decline for the S&P 500. The company brokered some key deals with Meta (Dhierin-Perkash Bechai is an ...